GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Buyback Yield %

ImmunoPrecise Antibodies (STU:TQB) Buyback Yield % : -3.17 (As of Dec. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

ImmunoPrecise Antibodies's current buyback yield was -3.17%.


ImmunoPrecise Antibodies Buyback Yield % Historical Data

The historical data trend for ImmunoPrecise Antibodies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Buyback Yield % Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.79 -5.19

ImmunoPrecise Antibodies Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -6.81

Competitive Comparison of ImmunoPrecise Antibodies's Buyback Yield %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's Buyback Yield % falls into.



ImmunoPrecise Antibodies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

ImmunoPrecise Antibodies's Buyback Yield for the fiscal year that ended in Apr. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.609) / 30.986175
=-5.19%

ImmunoPrecise Antibodies's annualized Buyback Yield for the quarter that ended in Jul. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0.33) * 4 / 19.384633
=-6.81%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Jul. 2024) data.


ImmunoPrecise Antibodies Buyback Yield % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

ImmunoPrecise Antibodies Headlines

No Headlines